We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

2 hedge funds and large institutions have $0 invested in Chinook Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 181 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 185 → 2 (-183)

100% less funds holding in top 10

Funds holding in top 10: 10 → 0 (-10)

100% less capital invested

Capital invested by funds: $2.24B → $0 (-$2.24B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 181

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-183
Holders Change %
-98.92%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
181
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
-$198M
2
FLSM
Frazier Life Sciences Management
California
-$167M
3
BlackRock
BlackRock
New York
-$164M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$113M
5
State Street
State Street
Massachusetts
-$112M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
76
UBS Group
Switzerland
– -$3.15M -82,016 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
– -$2.98M -77,692 Closed
HS
78
HighVista Strategies
Massachusetts
– -$2.92M -76,021 Closed
AG
79
Algert Global
California
– -$2.82M -73,406 Closed
EFI
80
EHP Funds Inc
Canada
– -$2.69M -70,000 Closed
PCM
81
Prelude Capital Management
New York
– -$2.55M -66,445 Closed
CC
82
Centiva Capital
New York
– -$2.37M -61,734 Closed
Walleye Capital
83
Walleye Capital
New York
– -$2.31M -60,012 Closed
HM
84
Harvest Management
New York
– -$2.31M -60,000 Closed
Ohio Public Employees Retirement System (OPERS)
85
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$2.31M -60,000 Closed
California State Teachers Retirement System (CalSTRS)
86
California State Teachers Retirement System (CalSTRS)
California
– -$2.3M -59,856 Closed
SG Americas Securities
87
SG Americas Securities
New York
– -$2.28M -59,342 Closed
Wells Fargo
88
Wells Fargo
California
– -$2.27M -59,152 Closed
CG
89
Carmignac Gestion
France
– -$2.18M -56,842 Closed
CS
90
Credit Suisse
Switzerland
– -$2M -51,931 Closed
WIC
91
Water Island Capital
New York
– -$1.98M -51,468 Closed
Legal & General Group
92
Legal & General Group
United Kingdom
– -$1.97M -51,153 Closed
State of Wisconsin Investment Board
93
State of Wisconsin Investment Board
Wisconsin
– -$1.9M -49,436 Closed
AA
94
ALPS Advisors
Colorado
– -$1.89M -49,166 Closed
New York State Common Retirement Fund
95
New York State Common Retirement Fund
New York
– -$1.83M -47,595 Closed
FC
96
FORA Capital
Florida
– -$1.6M -41,648 Closed
HWAM
97
Hennion & Walsh Asset Management
New Jersey
– -$1.54M -40,219 Closed
WAM
98
Wolverine Asset Management
Illinois
– -$1.51M -39,326 Closed
Invesco
99
Invesco
Georgia
– -$1.5M -39,106 Closed
OR
100
Olympiad Research
Connecticut
– -$1.5M -38,931 Closed
2 3
4
5 6

KDNY Hedge Fund Activity: Q3 2023 in Review

2 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q3 2023, worth a combined $0 — down 100% from $2.24B a quarter earlier.

Sellers outnumbered buyers: 181 funds closed out of KDNY and 0 opened new positions — a net loss of 181 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Samsara BioCapital, exiting entirely with an estimated $198M sold.

  • 2 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q3 2023, down from 185 in Q2 2023.
  • Funds reported $0 of Chinook Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q3 2023 and 181 closed out, a net change of -181 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q3 2023 was Samsara BioCapital, an estimated $198M sold.

Based on aggregated 13F filings for Q3 2023.